| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.005 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |